Switch View
© PR Newswire
09.10.2025
ISIN: US42227W2070
Healthcare Triangle Inc
HCTI
LISTED
NASDAQ
Healthcare Triangle Takes Bold Step toward AI-Driven Future with the Signing of a Non-Binding LOI for the Acquisition of Teyame.AI, which is on track to generate $34M in Revenue for fiscal year 2025 and would create for Healthcare Triangle a Next-Generati
News Preview
PLEASANTON, Calif., Oct. 9, 2025 /CNW/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced it has signed a non-binding Letter of Intent (LOI) to acquire the assets of Teyame.AI LLC ("Teyame"), a Spain...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US42227W2070
Healthcare Triangle Inc
HCTI
LISTED
NASDAQ
Healthcare Triangle Takes Bold Step toward AI-Driven Future with the Signing of a Non-Binding LOI for the Acquisition of Teyame.AI, which is on track to generate $34M in Revenue for fiscal year 2025 and would create for Healthcare Triangle a Next-Generati
News Preview
PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced it has signed a non-binding Letter of Intent (LOI) to acquire the assets of Teyame.AI LLC ("Teyame"),...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CNE100003N76
Shanghai Henlius Biotech, Inc.
2696
LISTED
HKSE
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission
News Preview
The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission
World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperative sett...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
09.10.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
09.10.2025
ISIN: US3179701012
Firefly Neuroscience, Inc.
AIFF
LISTED
NASDAQ
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Firefly Neuroscience, Inc. (NASDAQ: AIFF) on behalf of the company's shareholders. The investigation seeks to determine whether Firefly Neuroscience's directors breached their fiduciary duties in connection with...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Opill® Nails It with First-Ever Brand Collaboration, Launching 'Opill and Chill' With Chillhouse
News Preview
Brands Will Donate One Pack of Opill® to NY Birth Control Access Project for Each Opill®-Themed Chill Tips Set Sold
GRAND RAPIDS, Mich., Oct. 9, 2025 /PRNewswire/ -- Today, Perrigo Company plc (NYSE: PRGO), a leading provi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst Moisturizer
News Preview
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica®'s new packaging features a refreshed logo, modernized look, and luxe copper color palette.
The brand's new HA5® moisturizer
is designed to support...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced publication of its 2025 Post-Market Surveillance (PMS) Report. The report is being released ahead of the annual meeting of the American Society of Pl...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present two posters at the Canadian Society of Allergy and Clinical Immunology (CSACI) 80th Anniversary Scientific Meeting, taking place October 15-18, 2025 in Vancou...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akero Therapeutics, Inc. (NASDAQ: AKRO) to Novo Nordisk A/S is fair to Akero shareholders. Under the terms of the proposed transaction, Akero shareholders will receive $54.00 per share in cash, and a non-transferable Contingent Value Right entitling its holder to r...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the Autism Partnership Program to expand access to its industry leading exome and genome testing – the only autism testing program committed to delivering answers to families in weeks. Jaguar Gene Therapy joins the program as the foundin...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare unveils Carestation 850 at ANESTHESIOLOGY 2025: its next-generation anesthesia delivery system designed to adapt to care needs
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the unveiling of Carestation™ 850, its next-generation, FDA 510(k) pendingi anesthesia delivery system that is designed to help care teams adapt to evolving clinical and operational needs. Marking the latest evolution of GE HealthCare’s Carestation portfolio, Carestation 850 has the potential to advance...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
09.10.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting
News Preview
Overall survival recognized as key efficacy endpoint in osteosarcoma, where no standard of care existsRapporteur highlights potential broader benefits of OST-HER2 in pulmonary and primary osteosarcoma settings, supported by translational canine data from the University of PennsylvaniaNew York, New York--(Newsfile Corp. - October 9, 2025) - OS Thera...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: CA74447P1009
Psyched Wellness Ltd
PSYC
LISTED
CSE
Psyched Wellness Provides Comprehensive Investor Update
News Preview
Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to provide the following corporate update to i...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting
News Preview
ROCKVILLE, Md., Oct. 9, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present interim data from the Phase II ALTITUDE® trial evaluating suprachoroidal delivery of surabgene lomparvovec (ABBV-RGX-314, sura-vec) for the treatment of diabetic retinopathy (DR) at the American Academy...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Biopharma Leaders Advance the Future of Life Sciences at Veeva Commercial Summit Europe
News Preview
Industry gathers to explore Veeva AI innovations and exchange ideas with companies including Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna, and MSD
BARCELONA, Spain, Oct. 9, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Ast...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US74019P1084
Precision BioSciences Inc
DTIL
LISTED
NASDAQ
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases
News Preview
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the publication of a peer-reviewed manuscript titled “High-Efficiency Homology-Directed Insertion into the Genome using the Enginee...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IL0011595993
InMode Ltd.
INMD
LISTED
NASDAQ
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
News Preview
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time
YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the thir...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CA29668H1047
Essa Pharma, Inc.
EPIX
LISTED
NASDAQ
ESSA Announces Completion of Arrangement with XenoTherapeutics
News Preview
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /CNW/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics' ("Xeno") previously announced acquisition of ESSA (the "Acquisition").
Xeno Acquisition Corp., a wholly own...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: CA29668H1047
Essa Pharma, Inc.
EPIX
LISTED
NASDAQ
ESSA Announces Completion of Arrangement with XenoTherapeutics
News Preview
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics' ("Xeno") previously announced acquisition of ESSA (the "Acquisition").
Xeno Acquisition Corp., a who...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: GB00BP6S8Z30
Oxford Nanopore Technologies PLC
ONT
LISTED
LSE
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
News Preview
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit
Establishes a framework to define and propose future portfolios
Extends collaboration through 2032, reinforcing Bio-Techne's...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden™ Registrational Trial in Q4 2025
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the Company has completed discussions with the U.S. Food and Drug Administration (FDA) on its Embolden™ registrational trial protocol and plans to initiate dosing...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Announces First-Quarter 2026 Results
News Preview
Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter ended August 31, 2025.
“I see tremendous opportunity ahead to leverage Neogen’s strong, longstanding leadership in food and animal safety,” said Mike Nassif, Neogen’s Chief Executive Officer and President. “Few companies are as well-positioned as we are to help sh...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and prevention pipeline at the 20th European AIDS Conference (EACS 2025) taking place Oct.15-18, 2025, in Paris, France. The company’s presentations will include:
An oral presentation of weight and bo...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
News Preview
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 abstracts across more than 20 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be presented at the European Society for Medical Oncology (ESMO) Congress 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US00688A2050
Adial Pharmaceuticals Inc
ADIL
LISTED
NASDAQ
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
News Preview
Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
News Preview
CORAL GABLES, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for people living with rare and difficult-to-treat diseases, today announced that data developed by or in conjunction...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: GB0009895292
AstraZeneca PLC
AZN
LISTED
LSE
Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery
News Preview
LONDON, UK and BUDAPEST, HUNGARY, Oct. 9, 2025 /PRNewswire/ -- Turbine, a leading company specializing in virtualizing biological experiments with AI, today announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to test the ability of Turbine's platform to rationalize antibody-drug conjugate (ADC) disco...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West to Host Third-Quarter 2025 Conference Call
News Preview
EXTON, Pa., Oct. 9, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 23, 2025, and will follow with a co...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
News Preview
NEW HOPE, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced a data summary supporting the transformativ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention
News Preview
Breakthrough Therapy designation comes in addition to previously awarded Fast Track designation Breakthrough Therapy designation comes in addition to previously awarded Fast Track designation...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: CA59935V1076
Milestone Pharmaceuticals Inc.
MIST
LISTED
NASDAQ
Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025
News Preview
MONTREAL and CHARLOTTE, N.C., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present a poster presentation at the American Heart Association Scientific Sessions 2025, t...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US9183851057
vTv Therapeutics Inc.
VTVT
LISTED
NASDAQ
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
News Preview
Board to offer guidance on clinical development of cadisegliatin for type 1 diabetes as company has initiated Phase 3 trials Board to offer guidance on clinical development of cadisegliatin for type 1 diabetes as company has initiated Phase 3 trials...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces New Franchise Agreement and Real Estate Signed for Heal Wellness in Cochrane, Alberta
News Preview
Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce the signing of a franchise agreement and secured real estate for Cochrane, Alberta -a key market within the Compan...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: US6551872012
Aclarion, Inc.
ACON
LISTED
NASDAQ
Aclarion to Present at the LD Micro Main Event XIX
News Preview
Presentation on Monday, October 20, 2025 at 12:00 PM PTBroomfield, Colorado--(Newsfile Corp. - October 9, 2025) - Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location o...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: CA68617J1003
Organigram Global Inc
OGI
LISTED
NASDAQ
Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, is pleased to announce the launch of happly, its third U.S. hemp-derived delta-9 brand, created specifically for the growing segment of consumers seeking ‘mindful recreation’ with THC products. The launch of happly follow...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US7473241013
Pyxis Oncology Inc
PYXS
LISTED
NASDAQ
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
News Preview
BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced the appointment of Alex Kane, MBA, as Senior Vice President, Investor Relations & Capital Markets, effective immediately....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US00887A2042
Rein Therapeutics Inc
ALRN
LISTED
NASDAQ
Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
News Preview
AUSTIN, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it has received authorization from the European Medicines Agenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US02155X2053
Alterity Therapeutics Limited
ATHE
LISTED
NASDAQ
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
News Preview
– Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension –...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US83006G1040
60 Degrees Pharmaceuticals, Inc.
SXTP
LISTED
NASDAQ
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study
News Preview
60 Degrees Pharma unveils “B-FREE” Phase 2 trial for chronic babesiosis, engaging patients in naming and supporting Lyme research groups....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
News Preview
Operational Efficiencies and Focus on Profitability Drove Net Income of $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million Year-Over-Year...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US36269B1052
Gain Therapeutics, Inc.
GANX
LISTED
NASDAQ
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
News Preview
Event to be held October 14th at 4 p.m. EST Event to be held October 14th at 4 p.m. EST...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US8902604094
Tonix Pharmaceuticals Holding Corp.
TNXP
LISTED
NASDAQ
Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025
News Preview
CHATHAM, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced that Dr. Sina Bavari, Ph.D., Executive Vice President, Infectious Disease Research, will present a...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US53220K5048
Ligand Pharmaceuticals Inc
LGND
LISTED
NASDAQ
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
News Preview
Ligand Partner SQ Innovation Receives FDA Approval for
Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: SE0011205202
Vitrolife AB
VITR
LISTED
STO
Invitation to Vitrolife Group's presentation of the Q3 2025 interim report
News Preview
GOTHENBURG, Sweden, Oct. 9, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q3 2025 interim report on Thursday, 23 October 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day.
The presentation will be held in Eng...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
News Preview
Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US98985Y1082
Zymeworks Inc
ZYME
LISTED
NYSE
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
News Preview
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced the ap...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio
News Preview
Bagsværd, Denmark, 9 October, 2025 – Novo Nordisk today announced that it has entered into a definitive agreement to acquire Akero Therapeutics, Inc. (Akero), a publicly held clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need. Akero’s fibroblast growth factor 21 (...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies (OTC PINK:MDCE) Advances AI Research to Help Identify Early Health Risks in Skin Cancer, Vision, Wound Care, and Mental Wellness
News Preview
MESA, ARIZONA / ACCESS Newswire / October 9, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a developer of artificial intelligence-powered preventive health technology, today emphasized the urgent human need driving each vertical of its AI platform - underscoring the global lives lost and affected every year to conditions that may be better...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: US98401T1051
Xcelerate Inc.
XCRT
LISTED
OTC
Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group
News Preview
MAULDIN, SC / ACCESS Newswire / October 9, 2025 / Xcelerate, Inc. (OTC Markets:XCRT) today announced the sale of its majority interest in the ESN Group of companies, including ESN Group, Inc. and California Skin Research, Inc to Noble Labs Holdings, LLC, a company that had previously provided funding and marketing support to ESN Group, Inc. The tra...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: US85859W1027
Stemtech Corporation
STEK
LISTED
OTC
Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement
News Preview
NAPLES, FL, AL / ACCESS Newswire / October 9, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce an exclusive distribution agreement with Energy International Development Co., Ltd. to sell Stemtech products in Taiwan, R.O.C.The Taiwan MarketStemtech Corporation Chairman & CEO, Charles S. Arno...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
News Preview
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation. MIAMI, FL, 2654 / ACCESS Newswire / October 9, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology
News Preview
The published study results are from the ENLIGHT UC study (ES101002), a multicenter, randomized, double-blind and placebo-controlled Phase III trial of etrasimod conducted across Asia. The study included a 12-week induction phase followed by a 40-week maintenance phase and represents the largest pivotal Phase III...
Themefolio
Profiler
Peergroup
© EQS Newswire
09.10.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharma berichtet über die ersten neun Monate des Geschäftsjahres 2025
News Preview
Heidelberg Pharma berichtet über die ersten neun Monate des Geschäftsjahres 2025
Führender ADC-Kandidat HDP-101 zeigt weiterhin günstiges Sicherheits- und Verträglichkeitsprofil; klinische Studie schreitet in der neunten Kohorte mit einer erhöhten Dosis von 175 µg/kg fort
Verzögerung einer wesentlichen Meilensteinzahlung führt zu umfangreichen K......
Themefolio
Profiler
Peergroup
© EQS Newswire
09.10.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025
News Preview
Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025
Leading ADC candidate HDP-101 continues to demonstrate favorable safety and tolerability profile; clinical trial progresses into ninth cohort with increased dose of 175 µg/kg
Delay in significant milestone payment leads to extensive cost-saving measures, including a 75% re......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health Announces Results of Special Meeting of Shareholders
News Preview
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: CA53946V2066
Lobe Sciences Ltd.
LOBE
LISTED
CSE
Lobe Sciences Improves Balance Sheet
News Preview
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / October 9, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies through a scalable model of shared services, global teams, and outsourced infrastructure. The Company creates inte...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
